Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 22;36(3):291-297.
doi: 10.4103/tcmj.tcmj_174_23. eCollection 2024 Jul-Sep.

The beneficial effects of conservative treatment with biofeedback and electrostimulation on pelvic floor disorders

Affiliations

The beneficial effects of conservative treatment with biofeedback and electrostimulation on pelvic floor disorders

Mei-Chen Chen et al. Tzu Chi Med J. .

Abstract

Objectives: Pelvic floor disorders (PFDs) such as stress urinary incontinence (SUI) and pelvic organ prolapse (POP) can be managed through conservative treatments, such as conservative management involving biofeedback (BF) and electrostimulation. This study aimed to investigate the therapeutic effects of conservative treatments on PFDs.

Materials and methods: A retrospective cohort study was conducted. Women with PFD who underwent 1-3 months of BF and electrostimulation between January 1, 2020, and January 31, 2021, were included in the study. BF treatment was administered using three sensors to monitor pelvic floor muscle activity, providing patients with immediate feedback and guidance on muscle exercises. One session lasted for 5-10 min. Electrostimulation treatment utilized a specially made pelvic belt with electrode sheets to stimulate and contract pelvic floor muscles passively. One session lasted for 15 min. Six therapies in 1 month were prescribed. Pre- and post-treatment Pelvic Floor Distress Inventory (PFDI-20) scores, including POP distress inventory 6 (POPDI-6), colorectal-anal distress inventory (CRAD-8), and urinary distress inventory 6 (UDI-6) scores, were compared. Subgroup analysis by age, menopause, body mass index (BMI), and child delivery mode was performed.

Results: The study included 51 women with PFDs (SUI, POP, frequency or urgency or nocturia, and pain) treated with BF and electrostimulation, with a mean age of 49.94 ± 13.63 years. Sixteen patients (37.1%) were menopausal, with a mean menopause age of 50 ± 5.20 years. Twenty-six patients (68.4%) had a history of normal vaginal delivery. The mean PFDI-20 scores before and after treatment were 32.67 (standard deviation [SD] 10.05) and 25.99 (SD 9.61), respectively (P < 0.001). This decrease in scores reflected an improvement in subjective perceptions of symptoms and quality of life. The POPDI-6, CRAD-8, and UDI-6 scores significantly decreased after treatment. Subgroup analysis of scores change regarding age, menopause, BMI, and child delivery mode was not statistically significant.

Conclusion: The study demonstrated the effectiveness of BF and electrostimulation for treating women with PFDs. The findings contributed to the understanding of treatment duration, patient characteristics, and the potential benefits of a multimodal approach. Moreover, the study's diverse participant population and the use of validated outcome measures enhance the generalizability and scientific rigor of the findings.

Keywords: Biofeedback; Electrostimulation; Pelvic organ prolapse; Pelvic pain; Stress urinary incontinence.

PubMed Disclaimer

Conflict of interest statement

Dr.Dah-Ching Ding, an editorial board member at Tzu Chi Medical Journal, had no role in the peer review process of or decision to publish this article. The other authors declared no conflicts of interest in writing this paper.

Figures

Figure 1
Figure 1
Changes (percentage of pretreatment) in the Pelvic Floor Distress Inventory-20, pelvic organ prolapse distress inventory-6, Colorectal-Anal Distress Inventory-8, and urinary distress inventory-6 scores after conservative treatment with biofeedback and electrostimulation for pelvic floor disorders. PFDI-20: Pelvic Floor Distress Inventory-20, POPDI-6: pelvic organ prolapse distress inventory-6, CRAD-8: colorectal-Anal Distress Inventory, UDI-6: urinary distress inventory 6

Similar articles

Cited by

References

    1. Wu JM, Vaughan CP, Goode PS, Redden DT, Burgio KL, Richter HE, et al. Prevalence and trends of symptomatic pelvic floor disorders in U. S. Women. Obstet Gynecol. 2014;123:141–8. - PMC - PubMed
    1. Benti Terefe A, Gemeda Gudeta T, Teferi Mengistu G, Abebe Sori S. Determinants of pelvic floor disorders among women visiting the gynecology outpatient department in Wolkite University Specialized Center, Wolkite, Ethiopia. Obstet Gynecol Int 2022. 2022 6949700. - PMC - PubMed
    1. Kenne KA, Wendt L, Brooks Jackson J. Prevalence of pelvic floor disorders in adult women being seen in a primary care setting and associated risk factors. Sci Rep. 2022;12:9878. - PMC - PubMed
    1. Hallock JL, Handa VL. The epidemiology of pelvic floor disorders and childbirth: An update. Obstet Gynecol Clin North Am. 2016;43:1–13. - PMC - PubMed
    1. Beketie ED, Tafese WT, Assefa ZM, Berriea FW, Tilahun GA, Shiferaw BZ, et al. Symptomatic pelvic floor disorders and its associated factors in South-Central Ethiopia. PLoS One. 2021;16:e0254050. - PMC - PubMed

LinkOut - more resources